Aphranel® CaHA regenerative filler brand logo
aphranel®  News & Media

Aphranel® News & Media: CaHA Regenerative Aesthetics Updates

Our latest news

Brand News
Events & Forums
Global Perspectives
aphranel® Advances Global Medical Exchange Through “The Norns’ Weave,” Connecting Eastern and Western Aesthetic Perspectives
September 27, 2026

aphranel® Connects Eastern and Western Aesthetics Through “The Norns’ Weave”

Dr. Tiago Guimarães, accompanied by the aphranel® European Medical and Sales Team, visited four Chinese cities for clinical exchanges on CaHA applications, facial anatomy, and personalized aesthetic treatment strategies.
Learn more
aphranel® Named Official Partner of MXGP China 2026, Showcasing Chinese Innovation in Regenerative Aesthetics
September 13, 2026

aphranel® Joins MXGP China 2026 as an Official Partner

aphranel® joined MXGP China 2026 in Shanghai as an Official Partner, showcasing Chinese innovation in regenerative biomaterials and highlighting its commitment to scientific research, international certification, and global development.
Learn more
MOYOM Biotech Welcomes Strategic Investment from Cathay Capital to Support Global Growth
September 4, 2026

MOYOM Biotech Secures New Funding Round from Cathay Capital

MOYOM Biotech secured new financing from Cathay Capital's Beauty Future Fund to accelerate regenerative biomaterial research, product innovation, and commercialization, while expanding its presence in domestic and international markets.
Learn more
aphranel® Showcases Chinese Innovation in Regenerative Aesthetics at IMCAS China 2026
August 29, 2026

aphranel® Showcases Chinese Innovation at IMCAS China 2026

aphranel® presented its China-developed CaHA filler technology at IMCAS China 2026 in Shanghai, connecting international experts through scientific discussions on material science, clinical applications, and injection strategies.
Learn more
Aphranel® achieves EU MDR certification and begins scientific collaboration with Expert2Expert
July 7, 2026

APHRANEL® Achieves EU MDR Certification and Begins Scientific Collaboration with Expert2Expert

MOYOM advances APHRANEL® in Europe through EU MDR certification and a long-term scientific collaboration with Dr. Patrick Trévidic’s Expert2Expert team.
Learn more
Aphranel® first anniversary — EU MDR certification, Arc® launch and global expansion
May 20, 2026

aphranel® Marks First Anniversary With EU MDR Certification and 150,000+ Syringes Delivered

Following nearly 150,000 syringes distributed worldwide, aphranel® officially achieved EU MDR certification under Regulation (EU) 2017/745 during its first anniversary summit in Shanghai.
Learn more